A prospective study to determine half-life of aflibercept in aqueous humor after a single intravitreal injection in patients with neovascular age-related macular degeneration
Latest Information Update: 20 May 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Pharmacokinetics
- 20 May 2021 New trial record